"As the Company expands its clinical study sites in the US and Europe and responds to requests for access to Veyonda, it has focused on scaling up its manufacturing pipeline to supply this surge in demand."
NOX should be enquiring about schemes such as the TGA's special access scheme. Here is a link https://www.tga.gov.au/form/special-access-scheme
That way NOX can not only provide the treatment, but also get reimbursed for doing so, while collecting data at the same time. It may not seem like much but its still revenue and cash in the bank.
- Forums
- ASX - By Stock
- Ann: September 2021 Quarterly Activities Report and Appendix 4C
NOX
noxopharm limited
Add to My Watchlist
9.09%
!
4.8¢

"As the Company expands its clinical study sites in the US and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.8¢ |
Change
0.004(9.09%) |
Mkt cap ! $14.02M |
Open | High | Low | Value | Volume |
4.6¢ | 4.9¢ | 4.6¢ | $7.456K | 155.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 438181 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 163352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 370000 | 0.044 |
1 | 38819 | 0.043 |
3 | 588000 | 0.042 |
1 | 24390 | 0.041 |
3 | 295000 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 163352 | 1 |
0.056 | 46264 | 1 |
0.057 | 10730 | 1 |
0.061 | 16393 | 1 |
0.070 | 523 | 1 |
Last trade - 15.07pm 14/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |